GE Healthcare and Nvidia have launched a collaboration to develop AI-powered autonomous X-ray and ultrasound technologies, with an aim to address growing radiology staff shortages and improve imaging ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

In that effort, Scripps scientists are working with drug giant Merck to test a long-acting prodrug injectable of two HIV drugs made by Merck and Gilead, which licensed the development candidate in ...

Get Instant Summarized Text (Gist) Approximately 10% of South Asian immigrants aged 45 and older in Canada have hypothyroidism, with a 77% higher likelihood compared to Canadian-born individuals ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

This study was supported by Bristol-Myers Squibb. Milowsky disclosed stock ownership with Gilead Sciences, Merck, and Pfizer; receiving institutional research funding from BMS and others ...